REPLIMUNE GROUP INC

Ticker: REPL CUSIP: 76029N106 Class: Common Stock

Atlas Venture Life Science Advisors, LLC's Holding History (CIK: 0001917529)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 2,098,300 Value ($000) $18,885 Avg Close $6.97 Range $4.92 - $9.76
Q1 2024
Shares 2,098,300 Value ($000) $17,143 Avg Close $8.20 Range $6.75 - $9.50
Q4 2023
Shares 2,098,300 Value ($000) $17,689 Avg Close $11.59 Range $5.89 - $17.01
Q3 2023
Shares 2,098,300 Value ($000) $35,902 Avg Close $19.64 Range $15.62 - $23.60
Q2 2023
Shares 2,098,300 Value ($000) $48,723 Avg Close $19.54 Range $15.51 - $24.81
Q1 2023
Shares 2,098,300 Value ($000) $37,056 Avg Close $23.78 Range $16.89 - $29.52
Q4 2022
Shares 2,098,300 Value ($000) $57,074 Avg Close $20.78 Range $16.68 - $28.17
Q3 2022
Shares 3,108,300 Value ($000) $53,680 Avg Close $19.07 Range $15.07 - $21.63
Q2 2022
Shares 3,209,627 Value ($000) $56,104 Avg Close $16.43 Range $13.05 - $20.54
Q1 2022
Shares 3,209,627 Value ($000) $54,499 Avg Close $18.87 Range $14.97 - $30.89
Q4 2021
Shares 3,209,627 Value ($000) $86,981 Avg Close $29.91 Range $24.85 - $35.93